Kirstin Wingler
Maastricht, LI, Netherlands
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Genetic targeting or pharmacologic inhibition of NADPH oxidase nox4 provides renoprotection in long-term diabetic nephropathy.
Journal: Journal of the American Society of Nephrology : JASN
Published: February 11, 2014
Evolution of NADPH Oxidase Inhibitors: Selectivity and Mechanisms for Target Engagement.
Journal: Antioxidants & redox signaling
Published: January 04, 2014
NADPH oxidase, NOX1, mediates vascular injury in ischemic retinopathy.
Journal: Antioxidants & redox signaling
Published: September 24, 2013
NADPH oxidase 1 plays a key role in diabetes mellitus-accelerated atherosclerosis.
Journal: Circulation
Published: April 09, 2013
Neuroprotection after stroke by targeting NOX4 as a source of oxidative stress.
Journal: Antioxidants & redox signaling
Published: September 04, 2012
NOX4 is a Janus-faced reactive oxygen species generating NADPH oxidase.
Journal: Circulation research
Published: June 23, 2012
VAS2870 is a pan-NADPH oxidase inhibitor.
Journal: Cellular and molecular life sciences : CMLS
Published: June 14, 2012
The NOX toolbox: validating the role of NADPH oxidases in physiology and disease.
Journal: Cellular and molecular life sciences : CMLS
Published: April 18, 2012
The 1027th target candidate in stroke: Will NADPH oxidase hold up?
Journal: Experimental & translational stroke medicine
Published: April 05, 2012
NADPH oxidases as a source of oxidative stress and molecular target in ischemia/reperfusion injury.
Journal: Journal of molecular medicine (Berlin, Germany)
Published: March 01, 2012
Showing 1-11 of 11
Last Updated: 09/26/2026